Abstract Background Pain remains a significant clinical challenge, especially in chronic and treatment-resistant cases. Current pharmacological options often have limited efficacy and significant side effects, including dependence associated with opioids. FLT3 inhibitors, primarily developed for acute myeloid leukemia,...
Y. Moriya, R. Saito-Moriya, Y. Nago-Iwashita et al.· International Journal of Neu...· 0 citations
Abstract Background Alcohol-metabolizing genetic variants, ADH1B rs1229984 and ALDH2 rs671, are strongly associated with drinking behavior (Kranzler et al., 2019) and have also been linked to depressive symptoms (Hishimoto et al., 2010) and suicide-related behaviors (Yoshimasu et al., 2015). Whether these genetic varia...
Y. Nago-Iwashita, T. Kanata, M. Oba et al.· International Journal of Neu...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.